## PEP: PepsiCo, Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -2.0% below STRENGTH zone (3.0-6.0%); PEG 3.00 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($142.37)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. PepsiCo Stock (NASDAQ: PEP) News & Forecasts (Dec. 20, 2025): Elliott-Backed Cost Cuts, Walmart Lawsuit Overhang, and What Analysts Expect for 2026**
- Source: ts2.tech | 20251221T010853 | Neutral | Relevance: 100%
- PepsiCo is undergoing a strategic reset for 2026, influenced by activist investor Elliott Investment Management, focusing on cost cuts, SKU reductions, and value pricing to boost growth and margins amidst a flat stock performance in 2025. The company also faces a new class-action lawsuit alleging price-fixing with Walmart, while analysts have a mixed outlook for PEP stock, with a consensus "Hold" rating and varying price targets for next year. Despite these challenges, PepsiCo continues to be an attractive stock for income investors due to its strong dividend history and plans for increased cash returns.

**2. PepsiCo Stock (PEP) After Hours: Shares Dip After the Dec. 19, 2025 Close â€” Key News, Fresh Analyst Forecasts, and What to Watch Before the Next Session**
- Source: ts2.tech | 20251220T045308 | Neutral | Relevance: 100%
- PepsiCo (NASDAQ: PEP) saw its shares dip after the market close on December 19, 2025, amidst broader market gains, signaling investor focus on company-specific issues rather than overall market trends. Key developments include new analyst price target hikes from Bank of America, Citi, and JPMorgan, indicating optimism for 2026 execution, and ongoing considerations of the company's strategic outlook for 2026, leadership changes, and potential class-action litigation risks related to price-fixing allegations with Walmart. Investors are advised to monitor weekend developments concerning the Walmart lawsuit and ongoing execution of PepsiCo's strategic plan as they head into the next trading week.

**3. Matrix Asset Advisors Inc. NY Sells 23,488 Shares of PepsiCo, Inc. $PEP**
- Source: MarketBeat | 20251222T122750 | Neutral | Relevance: 100%
- Matrix Asset Advisors Inc. NY has reduced its stake in PepsiCo, Inc. (NASDAQ:PEP) by 10.7%, selling 23,488 shares in the third quarter. The firm now holds 196,977 shares valued at approximately $27.66 million, making PepsiCo its 13th largest holding. Analysts currently rate PepsiCo as a "Hold" with a consensus price target of $158.75, and the company recently announced a quarterly dividend of $1.4225 per share.

**4. Generali Investments CEE investicni spolecnost a.s. Has $9 Million Holdings in PepsiCo, Inc. $PEP**
- Source: MarketBeat | 20251222T110836 | Somewhat-Bullish | Relevance: 100%
- Generali Investments CEE investicni spolecnost a.s. increased its stake in PepsiCo (NASDAQ:PEP) by 20.9% in Q3, now holding 64,075 shares valued at nearly $9 million. PepsiCo announced a quarterly dividend of $1.4225, with an annualized yield of 3.8%. Analysts currently rate PepsiCo as a "Hold" with a consensus price target of $158.75.

**5. Brighton Jones LLC Raises Stake in PepsiCo, Inc. $PEP**
- Source: MarketBeat | 20251222T100943 | Bullish | Relevance: 100%
- Brighton Jones LLC significantly increased its stake in PepsiCo, Inc. by 16.4% in the third quarter of 2025, bringing their total holdings to 79,474 shares valued at $11.16 million. This comes as PepsiCo modestly beat quarterly earnings estimates and declared a quarterly dividend of $1.4225 per share. Institutional investors collectively own 73.07% of PepsiCo's stock.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $170 | $165 | +3% |
| 2025-12-11 | Barclays | $144 | $142 | +1% |
| 2025-12-10 | JP Morgan | $164 | $151 | +9% |
| 2025-12-09 | Piper Sandler | $172 | $161 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | main | Buy |
| 2025-12-11 | Barclays | main | Equal-Weight |
| 2025-12-10 | JP Morgan | up | Overweight |
| 2025-12-09 | Piper Sandler | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 34 ($10.12M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (-0.1%)
- Blackrock Inc.: 8.3% (+0.1%)
- JPMORGAN CHASE & CO: 4.5% (+98.0%)
- State Street Corpora: 4.2% (+1.8%)
- Geode Capital Manage: 2.4% (+1.8%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-5.1% 5d) with bearish MACD, trend may be turning.
2. Valuation stretched: PEG 3.0x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 4 raises (avg +5%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 3.00 signals overvaluation risk, limited margin of safety. Forward P/E 17.2x stretched relative to 6% growth. Quality metrics strong (ROE 37%). Balance sheet: $3.0B free cash flow. Insider buying signal ($10.1M), management confidence. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $201.3B |
| Beta | 0.42 |
| 52W Range | $127.60 - $160.15 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.00 |
| Forward P/E | 17.2 |
| Current P/E | 18.1 |
| YoY Growth | 5.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.1% to -2.0% (-5.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.0pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). RSI neutral at 47. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.05% (CS: 18) | Weak |
| RSI_14 | 47.1 | Neutral |
| MACD Histogram | -0.07 | Bearish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 0.994x | Below |
| vs SMA200 | 1.035x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $147.05
- **Stop Loss:** $142.37 (3.2% risk)
- **Target:** $151.73 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 128
- **Position Value:** $18,822.40
- **Portfolio %:** 18.82%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-03 (Est: $2.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.26 | $2.29 | +1.3% |
| 2025Q2 | $2.03 | $2.12 | +4.5% |
| 2025Q1 | $1.49 | $1.48 | -0.8% |
| 2024Q4 | $1.94 | $1.96 | +0.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*